Skip to main content
Home
language-selector-globe Korea | ko
Choose Location
  • Americas
  • Asia Pacific
  • Europe
  • International
  • Middle East & Africa
Argentina | Español
Brazil | Português
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Mexico | Español
United States | English
Australia | English
Bangladesh | English
Hong Kong S.A.R. | 繁體中文
India | English
Indonesia | English
Japan | 日本語
Korea | 한국어
Mainland China | 中文
Malaysia | English
Pakistan | English
Philippines | English
Singapore | English
Taiwan | 繁體中文
Thailand | ภาษาไทย
Austria | Deutsch
Belgium | Français
Belgium | Nederlands
Bulgaria | Български
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hungary | Magyar
Ireland | English
Italy | Italiano
Latvia | Latvian
Lithuania | Lithuanian
Netherlands | Nederlands
Norway | Norsk
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Serbia | Srpski
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Türkiye | Türkçe
United Kingdom | English
Global | English
Novartis Foundation | English
Egypt | English
Israel | עברית
Saudi Arabia | العربية
South Africa | English
language-selector-globe Korea
Choose Location
Americas Asia Pacific Europe International Middle East & Africa
Argentina | Español
Australia | English
Austria | Deutsch
Bangladesh | English
Belgium | Français
Belgium | Nederlands
Brazil | Português
Bulgaria | Български
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Egypt | English
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hong Kong S.A.R. | 繁體中文
Hungary | Magyar
India | English
Indonesia | English
Ireland | English
Israel | עברית
Italy | Italiano
Japan | 日本語
Korea | 한국어
Latvia | Latvian
Lithuania | Lithuanian
Mainland China | 中文
Malaysia | English
Mexico | Español
Netherlands | Nederlands
Norway | Norsk
Global | English
Novartis Foundation | English
Pakistan | English
Philippines | English
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Saudi Arabia | العربية
Serbia | Srpski
Singapore | English
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
South Africa | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Taiwan | 繁體中文
Thailand | ภาษาไทย
Türkiye | Türkçe
United Kingdom | English
United States | English
    • 회사소개 
      • 주요 전략 
      • 직원과 기업문화 
      • 다양성과 포용성 
      • 제품정보  
      • 노바티스그룹 경영진 
      • 핵심 사업부문 
      • 연락처 
      About Novartis Korea 회사소개
    • 환자와 보호자 
      • 환자와 보호자에 대한 노바티스의 약속 
      • 주요 질병 분야 
      • 제품정보  
      • 부작용 보고 
      A couple holding hands 환자와 보호자
    • 의료전문가 
      • 메드허브 
      • 제품정보  
      • 부작용 보고 
      • 혁신 
      • 글로벌 정보서비스 
      Novartis Health Care 의료전문가
    • 혁신 
      • 임상시험 
      • 기술 플랫폼 
      • 데이터와 디지털 
      • 한국노바티스의 혁신 
      • 노바티스의 혁신 
      • 노바티스 생명의학연구소(NIBR) 
      Novartis Innovation 혁신
    • 환경, 사회 및 가브넌스 
      • 윤리 위험 및 규정준수 
      • 의약품 접근성 
      • 환경지속가능성 
      • 글로벌 헬스 
      • 윤리적 행동양식 
      • 한국노바티스의 사회적 책임 
      Novartis ESG 환경, 사회 및 가브넌스
    • 뉴스룸 
      • 보도자료  
      • 이노베이션 스토리  
      • 자료실 
        • 의약품 회수에 관한 공표 
      Novartis News 뉴스룸
    • 인재채용 
      • 채용 공고 
      • 우리가 일하는 방식 
      • 웰빙 
      • 다양성과 포용성  
      • 수상내역 
      Novartis Careers 인재채용
    • Coronavirus 
      multiple coronavirus illustration edit image_1 코로나바이러스감염증-19 (COVID-19) 업데이트
    Seoul Skyline Home
  1. Home
  2. 인재채용
  3. 채용 공고
  • Sort by Sort ascending
  • Job Title
  • Site
  • Location
  • Division
  • Business
  • Functional Area
  • Date Posted Sort descending
Job Title Site Location Division Business Functional Area Date Posted Sort descending
Sr. Spec. DDIT IES Cloud Engineering Hyderabad (Office) India Operations CTS Technology Transformation Oct 11, 2024
Sr Specialist - DevOps Engineer Hyderabad (Office) India Operations CTS Technology Transformation Oct 11, 2024
Real Estate Lead, Data & Technology Prague Czech Republic Operations CTS Facilities & Administration Oct 11, 2024
Associate Director - Risk & Assurance, EUROPE Prague Czech Republic Ethics Risk & Compliance Innovative Medicines Legal & Intellectual Property & Compl. Oct 11, 2024
Digital Finance, Data & Tools Analyst Barcelona Gran Vía Spain Finance CTS Audit & Finance Oct 11, 2024
GCP Bioanalysis Senior Scientist Basel (City) Switzerland Biomedical Research Pharma Research Research & Development Oct 11, 2024
Associate Director, IT Site Business Partner for Technical R&D Ivrea Italy Operations Innovative Medicines Technology Transformation Oct 11, 2024
Financial Reporting & Accounting Specialist Baarle Nassau Netherlands Finance Sandoz Audit & Finance Oct 11, 2024
Senior Finance Specialist – Digital Analytics and Operations Barcelona Gran Vía Spain Finance Innovative Medicines Audit & Finance Oct 11, 2024
Production Technician St-Genis-Prod France Operations Innovative Medicines Technical Operations Oct 11, 2024
Allergy-Territory Account Specialist – Seattle E, WA – Remote Field Sales (USA) USA US Innovative Medicines Sales Oct 11, 2024
Good Clinical Practices and Pharmacovigilance Sr. Auditor INSURGENTES Mexico Operations Innovative Medicines Quality Oct 11, 2024
Senior Clinical Data Scientist Dublin (Novartis Corporate Center (NOCC)) Ireland Development Innovative Medicines Research & Development Oct 11, 2024
Sales Value Manager Speciality Care INSURGENTES Mexico International Innovative Medicines Sales Oct 11, 2024
Associate Director, Non-Clinical Statistics Cambridge (USA) USA Biomedical Research Pharma Research Research & Development Oct 11, 2024
Production Manager Carlsbad USA Operations Innovative Medicines Technical Operations Oct 11, 2024
Global GMP Senior Quality Auditor Toronto Canada Operations Innovative Medicines Quality Oct 11, 2024
Senior GCP/PV Auditor Toronto Canada Operations Innovative Medicines Quality Oct 11, 2024
Process Expert - Comecer Lines Indianapolis USA Operations Innovative Medicines Technical Operations Oct 11, 2024
Senior Manager, New Product Planning Montreal Canada International Innovative Medicines Market Access Oct 11, 2024
Talent Acquisition Coordinator INSURGENTES Mexico People & Organization CTS Human Resources Oct 11, 2024
Production Technician I, PM Shift Millburn USA Operations Innovative Medicines Technical Operations Oct 11, 2024
Chef principal, Planification de nouveaux produits Montreal Canada International Innovative Medicines Market Access Oct 11, 2024
(高级)医药代表 /(资深)产品专员 Guiyang (Guizhou Province) China International Innovative Medicines Sales Oct 11, 2024
(高级)医药代表 /(资深)产品专员 Guiyang (Guizhou Province) China International Innovative Medicines Sales Oct 11, 2024
(高级)医药代表 /(资深)产品专员 Guiyang (Guizhou Province) China International Innovative Medicines Sales Oct 11, 2024
(高级)医药代表 /(资深)产品专员 Guiyang (Guizhou Province) China International Innovative Medicines Sales Oct 11, 2024
(高级)医药代表 /(资深)产品专员 Guiyang (Guizhou Province) China International Innovative Medicines Sales Oct 11, 2024
(高级)医药代表 /(资深)产品专员 Dazhou (Sichuan Province) China International Innovative Medicines Sales Oct 11, 2024
(高级)医药代表 /(资深)产品专员 Huhehaote (Neimenggu Province) China International Innovative Medicines Sales Oct 11, 2024
Clinical Sciences Trial Leader Cambridge (USA) USA Biomedical Research Pharma Research Research & Development Oct 12, 2024
Neuroscience Territory Account Specialist – Denver - Remote Field Sales (USA) USA US Innovative Medicines Sales Oct 12, 2024
Global QMS RDQ Specialist Hyderabad (Office) India Development Innovative Medicines Quality Oct 13, 2024
(高级)医药代表 /(资深)产品专员 Kaifeng (Henan Province) China International Innovative Medicines Sales Oct 13, 2024
县域主任(主管) Xinyang (Henan Province) China International Innovative Medicines Sales Oct 13, 2024
(高级)医药代表 /(资深)产品专员 Urumqi (Xinjiang Province) China International Innovative Medicines Sales Oct 13, 2024
Technicien de laboratoire CQ 5x8 – CDI (h/f) Huningue France Operations Innovative Medicines Quality Oct 14, 2024
Senior MR Shenzhen (Guangdong Province) China International Innovative Medicines Sales Oct 14, 2024
Central Integrated Scientific Review Committee Lead Dublin (Novartis Corporate Center (NOCC)) Ireland Development Innovative Medicines Research & Development Oct 14, 2024
Associate Director, Clinical Processes & Solutions Dublin (Novartis Corporate Center (NOCC)) Ireland Development Innovative Medicines Research & Development Oct 14, 2024
(高级)医药代表 /(资深)产品专员 Guiyang (Guizhou Province) China International Innovative Medicines Sales Oct 14, 2024
(高级)医药代表 /(资深)产品专员 Linfen (Shanxi Province) China International Innovative Medicines Sales Oct 14, 2024
Senior MR Shenzhen (Guangdong Province) China International Innovative Medicines Sales Oct 14, 2024
(高级)医药代表 /(资深)产品专员 Guiyang (Guizhou Province) China International Innovative Medicines Sales Oct 14, 2024
(高级)医药代表 /(资深)产品专员 Linfen (Shanxi Province) China International Innovative Medicines Sales Oct 14, 2024
Senior MR Shenzhen (Guangdong Province) China International Innovative Medicines Sales Oct 14, 2024
Medical Head Oncology Milano Italy International Innovative Medicines Research & Development Oct 14, 2024
(高级)医药代表 /(资深)产品专员 Guiyang (Guizhou Province) China International Innovative Medicines Sales Oct 14, 2024
(高级)医药代表 /(资深)产品专员 Linfen (Shanxi Province) China International Innovative Medicines Sales Oct 14, 2024
Senior MR Shenzhen (Guangdong Province) China International Innovative Medicines Sales Oct 14, 2024

Pagination

  • ‹ Previous page
  • 1
  • …
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • …
  • 42
  • › Next page

한국노바티스

Navigate Novartis
  • 회사소개
  • 환자와 보호자
  • 의료전문가
  • 혁신
  • 환경, 사회 및 가브넌스
  • 뉴스룸
  • 인재채용
Media Center
  • 보도자료
  • 이노베이션 스토리
Other Novartis Websites in Korea
  • MedHub
  • Novartis Global
  • 한국노바티스 LinkedIn
  • 한국노바티스 YouTube
Footer Bottom
© 2024 Novartis AG
  • 개인정보 처리방침
  • 이용약관
  • Cookie Settings
  • Site Map
  • Web Accessibility
Novartis Site Directory
이 사이트는 국내 거주자들을 위한 사이트입니다. KR2205234431